Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial
Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedFooter revision indicators were updated: added Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check61 days agoChange DetectedNo additions or deletions were observed. The page content appears unchanged.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.4.2 added; the funding-lapse notice and Revision: v3.4.1 were removed; these are site-wide updates and do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedA site-wide notice about a lapse in government funding and the page revision updated to v3.4.1 were added, replacing the previous revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.